944 related articles for article (PubMed ID: 29254665)
21. Amyloid and tau PET demonstrate region-specific associations in normal older people.
Lockhart SN; Schöll M; Baker SL; Ayakta N; Swinnerton KN; Bell RK; Mellinger TJ; Shah VD; O'Neil JP; Janabi M; Jagust WJ
Neuroimage; 2017 Apr; 150():191-199. PubMed ID: 28232190
[TBL] [Abstract][Full Text] [Related]
22. Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech.
Utianski RL; Whitwell JL; Schwarz CG; Senjem ML; Tosakulwong N; Duffy JR; Clark HM; Machulda MM; Petersen RC; Jack CR; Lowe VJ; Josephs KA
Cortex; 2018 Feb; 99():358-374. PubMed ID: 29353121
[TBL] [Abstract][Full Text] [Related]
23. The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.
Vermeiren C; Motte P; Viot D; Mairet-Coello G; Courade JP; Citron M; Mercier J; Hannestad J; Gillard M
Mov Disord; 2018 Feb; 33(2):273-281. PubMed ID: 29278274
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study.
Sullivan KJ; Liu A; Chang CH; Cohen AD; Lopresti BJ; Minhas DS; Laymon CM; Klunk WE; Aizenstein H; Nadkarni NK; Loewenstein D; Kamboh MI; Ganguli M; Snitz BE
Brain Imaging Behav; 2021 Jun; 15(3):1355-1363. PubMed ID: 32748322
[TBL] [Abstract][Full Text] [Related]
25. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.
Villemagne VL; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Hodges J; Harada R; Yates P; Piguet O; Pejoska S; Doré V; Yanai K; Masters CL; Kudo Y; Rowe CC; Okamura N
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):816-26. PubMed ID: 24514874
[TBL] [Abstract][Full Text] [Related]
26. The influence of β-amyloid on [
Whitwell JL; Martin PR; Duffy JR; Clark HM; Machulda MM; Schwarz CG; Weigand SD; Sintini I; Senjem ML; Ertekin-Taner N; Botha H; Utianski RL; Graff-Radford J; Jones DT; Boeve BF; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
Neurology; 2019 Feb; 92(7):e710-e722. PubMed ID: 30635491
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
Wang L; Benzinger TL; Su Y; Christensen J; Friedrichsen K; Aldea P; McConathy J; Cairns NJ; Fagan AM; Morris JC; Ances BM
JAMA Neurol; 2016 Sep; 73(9):1070-7. PubMed ID: 27454922
[TBL] [Abstract][Full Text] [Related]
28. In vivo retention of
Smith R; Schöll M; Widner H; van Westen D; Svenningsson P; Hägerström D; Ohlsson T; Jögi J; Nilsson C; Hansson O
Neurology; 2017 Aug; 89(8):845-853. PubMed ID: 28754841
[TBL] [Abstract][Full Text] [Related]
29. Lower in vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer's pathology: a cohort study.
Engels-Domínguez N; Koops EA; Hsieh S; Wiklund EE; Schultz AP; Riphagen JM; Prokopiou PC; Hanseeuw BJ; Rentz DM; Sperling RA; Johnson KA; Jacobs HIL
Alzheimers Res Ther; 2024 Jun; 16(1):129. PubMed ID: 38886798
[TBL] [Abstract][Full Text] [Related]
30. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease.
Iaccarino L; Tammewar G; Ayakta N; Baker SL; Bejanin A; Boxer AL; Gorno-Tempini ML; Janabi M; Kramer JH; Lazaris A; Lockhart SN; Miller BL; Miller ZA; O'Neil JP; Ossenkoppele R; Rosen HJ; Schonhaut DR; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2018; 17():452-464. PubMed ID: 29159058
[TBL] [Abstract][Full Text] [Related]
31. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.
Koivumäki M; Ekblad L; Lantero-Rodriguez J; Ashton NJ; Karikari TK; Helin S; Parkkola R; Lötjönen J; Zetterberg H; Blennow K; Rinne JO; Snellman A
Alzheimers Res Ther; 2024 May; 16(1):112. PubMed ID: 38762725
[TBL] [Abstract][Full Text] [Related]
32. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
[TBL] [Abstract][Full Text] [Related]
33. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
Gomperts SN; Locascio JJ; Makaretz SJ; Schultz A; Caso C; Vasdev N; Sperling R; Growdon JH; Dickerson BC; Johnson K
JAMA Neurol; 2016 Nov; 73(11):1334-1341. PubMed ID: 27654968
[TBL] [Abstract][Full Text] [Related]
34. In vivo binding of a tau imaging probe, [
Endo H; Shimada H; Sahara N; Ono M; Koga S; Kitamura S; Niwa F; Hirano S; Kimura Y; Ichise M; Shinotoh H; Zhang MR; Kuwabara S; Dickson DW; Toda T; Suhara T; Higuchi M
Mov Disord; 2019 May; 34(5):744-754. PubMed ID: 30892739
[TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
[TBL] [Abstract][Full Text] [Related]
36. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
37. Subthreshold Amyloid Predicts Tau Deposition in Aging.
Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
[TBL] [Abstract][Full Text] [Related]
38. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
[TBL] [Abstract][Full Text] [Related]
39. Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging.
Elias A; Cummins T; Tyrrell R; Lamb F; Dore V; Williams R; Rosenfeld JV; Hopwood M; Villemagne VL; Rowe CC
J Alzheimers Dis; 2018; 66(2):733-741. PubMed ID: 30320587
[TBL] [Abstract][Full Text] [Related]
40. Subcortical
Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
